C. Escuriola‐Ettingshausen
Krankenhaus Porz am Rhein(DE)
Publications by Year
Research Areas
Hemophilia Treatment and Research, Platelet Disorders and Treatments, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A(2013)214 cited
- → When should prophylactic treatment in patients with haemophilia A and B start?— The German experience(1998)156 cited
- → The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab(2019)93 cited
- → Inhibitor development and mortality in non‐severe hemophilia A(2015)74 cited
- → Immune tolerance induction: What have we learned over time?(2018)63 cited
- → Epidemiology of Inhibitors in Haemophilia A(1996)55 cited
- → Radiological and orthopedic score in pediatric hemophilic patients with early and late prophylaxis(1998)44 cited
- → Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel(2020)36 cited
- → Intensity of factor VIII treatment and the development of inhibitors in non‐severe hemophilia A patients: results of the INSIGHT case–control study(2017)36 cited
- → Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia A(2020)35 cited